Actively Recruiting
Navitor Transcatheter Aortic Valve Implantation Study in Japanese Patients with Severe Aortic Stenosis A Post-Market Evaluation of Safety and Performance Using the FlexNav Delivery System
Led by Abbott Medical Devices · Updated on 2026-05-26
100
Participants Needed
3
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and performance of the Navitor valve used with the FlexNav delivery system in Japanese patients with symptomatic, severe aortic stenosis. This observational study is designed to understand how the Navitor TAVI system works in real-world settings, including future versions as they become available in Japan. Approximately 100 patients will participate to help assess the devices use after approval. Participants will undergo transcatheter aortic valve implantation TAVI using the Navitor valve, FlexNav Delivery system, and Navitor Loading System. This single-arm study will follow patients after their procedure, with check-ins at hospital discharge, 30 days, and one year later to monitor safety and device performance over time. During the study, patients will attend scheduled follow-up visits to assess outcomes and any potential issues. Researchers will monitor safety and performance endpoints 30 days after the procedure and continue to observe patients for up to one year. The study aims to gather detailed information on how well the device works and its safety in everyday clinical practice.
CONDITIONS
Brief Title
Navitor Japan Study
Research Team
B
Bart Janssens
A
Alicia Kimber
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here